LU76150A1 - - Google Patents

Info

Publication number
LU76150A1
LU76150A1 LU76150A LU76150A LU76150A1 LU 76150 A1 LU76150 A1 LU 76150A1 LU 76150 A LU76150 A LU 76150A LU 76150 A LU76150 A LU 76150A LU 76150 A1 LU76150 A1 LU 76150A1
Authority
LU
Luxembourg
Application number
LU76150A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to LU76150A priority Critical patent/LU76150A1/xx
Priority to NL7712100A priority patent/NL7712100A/xx
Priority to DE19772749318 priority patent/DE2749318A1/de
Priority to FR7733216A priority patent/FR2369841A1/fr
Priority to AU30418/77A priority patent/AU3041877A/en
Priority to ZA00776645A priority patent/ZA776645B/xx
Priority to IL53318A priority patent/IL53318A0/xx
Priority to BE182381A priority patent/BE860526A/xx
Priority to JP13316577A priority patent/JPS5359035A/ja
Publication of LU76150A1 publication Critical patent/LU76150A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU76150A 1976-11-08 1976-11-08 LU76150A1 (https=)

Priority Applications (9)

Application Number Priority Date Filing Date Title
LU76150A LU76150A1 (https=) 1976-11-08 1976-11-08
NL7712100A NL7712100A (nl) 1976-11-08 1977-11-02 Farmaceutische preparaten.
DE19772749318 DE2749318A1 (de) 1976-11-08 1977-11-04 Pharmazeutische praeparate
FR7733216A FR2369841A1 (fr) 1976-11-08 1977-11-04 Preparations pharmaceutiques contenant un derive de propanol et un tranquillisant mineur
AU30418/77A AU3041877A (en) 1976-11-08 1977-11-07 Benzodiazepine - propanol derivative compositions
ZA00776645A ZA776645B (en) 1976-11-08 1977-11-07 Pharmaceutical preparations
IL53318A IL53318A0 (en) 1976-11-08 1977-11-07 Novel pharmaceutical preparations for treating tension and anxiety states comprising phenoxy propanol amines
BE182381A BE860526A (fr) 1976-11-08 1977-11-07 Preparations pharmaceutiques contenant un derive de propanol et un tranquilisant mineur
JP13316577A JPS5359035A (en) 1976-11-08 1977-11-08 Medical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU76150A LU76150A1 (https=) 1976-11-08 1976-11-08

Publications (1)

Publication Number Publication Date
LU76150A1 true LU76150A1 (https=) 1978-07-10

Family

ID=19728406

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76150A LU76150A1 (https=) 1976-11-08 1976-11-08

Country Status (9)

Country Link
JP (1) JPS5359035A (https=)
AU (1) AU3041877A (https=)
BE (1) BE860526A (https=)
DE (1) DE2749318A1 (https=)
FR (1) FR2369841A1 (https=)
IL (1) IL53318A0 (https=)
LU (1) LU76150A1 (https=)
NL (1) NL7712100A (https=)
ZA (1) ZA776645B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468391A (en) * 1982-06-25 1984-08-28 Ayerst, Mckenna & Harrison, Inc. Combination of β-adrenoceptor antagonists and anxiolytic agents
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1919342A1 (de) * 1969-04-16 1970-12-03 Boehringer Sohn Ingelheim Herzwirksame Kombinationspraeparate

Also Published As

Publication number Publication date
DE2749318A1 (de) 1978-05-11
ZA776645B (en) 1978-08-30
AU3041877A (en) 1979-05-17
JPS5359035A (en) 1978-05-27
IL53318A0 (en) 1978-01-31
NL7712100A (nl) 1978-05-10
FR2369841A1 (fr) 1978-06-02
BE860526A (fr) 1978-05-08

Similar Documents

Publication Publication Date Title
FR2359485B1 (https=)
JPS563071B2 (https=)
JPS5611954B2 (https=)
JPS5638911Y2 (https=)
FR2360739B3 (https=)
JPS532073U (https=)
CS192123B1 (https=)
JPS5299934U (https=)
JPS5329677U (https=)
JPS5364110U (https=)
CS176988B1 (https=)
CS177400B1 (https=)
CS177436B1 (https=)
CS177783B1 (https=)
CS178396B1 (https=)
CH614380A5 (https=)
CH606943A5 (https=)
DD123261A1 (https=)
DD123394A1 (https=)
DD123585A6 (https=)
DD124411A1 (https=)
DD124413A1 (https=)
LU76150A1 (https=)
DD123523A1 (https=)
DD123785A1 (https=)